EQT, Silver Lake and Nestlé Expand Partnership with €3.5bn Investment in IVC Evidensia
February 9, 2021
IVC Evidensia has secured an aggregated new investment of €3.5 billion that values the company at an enterprise value of approximately €12.3 billion. The expanded partnership includes a substantial reinvestment by EQT Private Equity, a new minority investment from Silver Lake, and an increased minority stake from Nestlé Purina PetCare EMENA to support digitalisation and further growth across IVC's network of clinics.
- Buyers
- EQT Private Equity, Silver Lake, Nestlé Purina PetCare EMENA
- Targets
- IVC Evidensia
- Sellers
- EQT VII (EQT Private Equity) (partial exit)
- Industry
- Veterinary
- Location
- England, United Kingdom
- Transaction Type
- Recapitalization
Explore More
Related Acquisitions
-
Esco Lifesciences Group Acquires Evidence Solution
July 6, 2022
Software
Esco Lifesciences Group announced the full acquisition of Evidence Solution, a Denmark-based software company that provides IVF witnessing, labelling, workflow scheduling and traceability systems. Esco said it will integrate Evidence's witnessing technology into its IVF device portfolio to improve workflow productivity and compliance in fertility clinics.
-
Buenavista Equity Partners (via Evidenze) Acquires Chrestos Concept GmbH & Co. KG
November 22, 2024
Healthcare Services
Buenavista Equity Partners has acquired German CRO Chrestos Concept GmbH & Co. KG through its healthcare platform Evidenze Group Europe. The add-on expands Evidenze's capabilities in clinical trial design, biostatistics and data science and strengthens its presence in Germany as part of a buy-and-build strategy.
-
EQT to Acquire VetPartners from National Veterinary Associates
October 11, 2023
Veterinary
EQT has agreed to acquire VetPartners, the largest provider of veterinary and animal health services in Australia and New Zealand, from National Veterinary Associates. VetPartners operates a network of 267 clinics and specialty hospitals with over 4,300 clinical and support staff; EQT says it will invest in diagnostic equipment, technology, recruitment and training to support continued growth and improved clinical outcomes. The transaction is subject to customary approvals and is expected to close around the end of the calendar year.
-
EQT Acquires LSP (Life Sciences Partners)
November 10, 2021
Financial Services
EQT AB has acquired LSP (Life Sciences Partners), a leading European life-sciences venture capital firm, in a transaction that creates a new EQT Life Sciences business line. The deal values the upfront consideration at EUR 450 million (25% cash / 75% EQT shares) with a EUR 25 million earn‑out paid on meeting fundraising targets (total consideration EUR 475 million at close); LSP's 34-person team and partners join EQT to strengthen its healthcare investing capabilities.
-
Silver Economy Fund (Quadrivio Group) Acquires Majority Stake in SIARE International Engineering
May 19, 2023
Medical Devices
Silver Economy Fund, a private equity fund managed by Quadrivio Group, has signed an agreement to acquire a majority stake in SIARE International Engineering S.r.l., an Italian manufacturer of electromedical devices for anaesthesia, resuscitation and pulmonary ventilation. Founder Giuseppe Preziosa will remain as President and will reinvest in the company while the fund will pursue growth and consolidation via management strengthening, international expansion and distribution-channel enhancements.
-
EQT Life Sciences and Gimv Co-Lead €51M Series B in Exciva
January 20, 2026
Biotechnology
EQT Life Sciences (via its LSP Dementia Fund) and Gimv co-led a €51 million Series B in German clinical-stage biopharmaceutical company Exciva to fund a Phase 2 trial of its lead candidate, Deraphan, for agitation associated with Alzheimer's disease. Additional participants included Fountain Healthcare Partners, LifeArc, Carma Fund, Modi Ventures, Andera Partners, LBBW and returning investors; proceeds will support multinational Phase 2 studies across the EU, United States and Canada.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.